Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-03-06 @ 3:09 PM
Study NCT ID:
NCT00642603
Status:
TERMINATED
Last Update Posted:
2018-03-29
First Post:
2008-03-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML21567
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Disclosures Group
Old Organization:
Hoffmann-La Roche